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Design, Setting, and Patients:	We	 analyzed	 data	 reported	 from	
U.S.	 healthcare	 facilities	 for	 ventilator-associated	 events	 that	
occurred	in	2014,	the	first	year	during	which	ventilator-associated	 
event	surveillance	definitions	were	stable.	We	used	negative	bino-





Measurements and Main Results:	 A	 total	 of	 1,824	 healthcare	
facilities	reported	32,772	location	months	of	ventilator-associated	

















Ventilator-associated pneumonia (VAP) has long been recognized as a patient safety threat. The Centers for Disease Control and Prevention (CDC) began con-
ducting VAP surveillance in U.S. healthcare facilities in the 
1970s: first in the National Nosocomial Infections Surveillance 
system (NNIS) and then in the National Healthcare Safety Net-
work (NHSN) from 2006 to the present. NNIS and NHSN VAP 
surveillance definitions and methods were developed for use by 
hospitals in internal quality improvement efforts, years before 
the advent of state healthcare-associated infection (HAI) pub-
lic reporting mandates and federal pay-for-reporting and 
-performance programs. Public reporting and federal incen-
tive programs highlighted the limitations of VAP diagnostic 
criteria (1, 2), spurring development of a more objective and 
potentially automatable approach to public health surveillance 
for ventilator-associated conditions (VAC) and complications. 
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This approach, termed “ventilator-associated event” (VAE) 
surveillance, was designed to capture an array of noninfection- 
and infection-related events in patients receiving mechanical 
ventilation and was implemented in NHSN in January 2013 
for use in adult patients (3). VAE definitions were not designed 
to replace VAP as a clinical entity nor to be used in the clinical 
care of individual patients, and some studies, not surprisingly, 
have shown that there is poor correlation between VAEs and 
events detected by traditional VAP definitions (https://shea.
confex.com/shea/2011/webprogram/Paper4111.html) (4–7).
Between 2013 and 2014, based on feedback from NHSN 
users and input from an expert working group, several changes 
to the VAE definitions were made. The first full year of surveil-
lance using stable definitions occurred in 2014. We analyzed 
VAE data reported to NHSN according to the surveillance 
protocol to determine incidence rates and describe event 
characteristics.
MATERIALS AND METHODS
Data Source and Definitions
We analyzed VAE data reported to NHSN with event dates in 
2014, using data reported through May 2015. Users are able to 
update their NHSN data at any time, and analyses of datasets 
from later months may yield slightly different results. In 2014, 
participation in VAE surveillance was limited to adult inpatient 
locations in acute care hospitals, long-term acute care hospitals 
(LTACHs), and inpatient rehabilitation facilities, and surveil-
lance was voluntary. Among states, only Pennsylvania had a 
VAE reporting mandate, and VAE was not included in federal 
pay-for-reporting or -performance programs. We included 
VAEs and denominator data from locations that reported both 
numerator and denominator data during at least 1 month of 
2014 in accordance with the NHSN surveillance protocol. This 
project was determined to be nonresearch public health sur-
veillance by CDC.
Incidence and Event Characteristics
VAE surveillance definitions identify three syndromes: VAC, 
infection-related ventilator-associated complications (IVAC), 
and possible or probable ventilator-associated pneumonias 
(PoVAP or PrVAP; combined in 2015 into a single possible 
VAP [PVAP] definition) (Supplemental Material, Supple-
mental Digital Content 1, http://links.lww.com/CCM/B934). 
We determined rates of overall VAE (i.e., all events meeting at 
least the VAC definition) and IVAC-plus (i.e., all events meet-
ing at least the IVAC definition) per 1,000 ventilator days. 
Data were analyzed in SAS version 9.3 (SAS Institute, Cary, 
NC). VAE rates were first stratified based on NHSN inpatient 
location type (http://www.cdc.gov/nhsn/PDFs/pscManual/1
5LocationsDescriptions_current.pdf), which has been a stan-
dard approach for reporting NHSN device-associated event 
data (8). To determine whether these location types should 
be further stratified, we used negative binomial regression 
modeling to explore additional variables, including facility 
medical school affiliation and postgraduate medical training 
program type (for cardiac, medical, medical-surgical, car-
diothoracic surgical, and surgical ICUs) and unit bed size 
(for medical-surgical ICUs without major teaching affilia-
tions). Facility medical training program types are defined 
in NHSN documentation (http://www.cdc.gov/nhsn/pdfs/
pscmanual/16psckeyterms_current.pdf). The final model 
was selected based on parsimony and goodness of fit using 
the Akaike Information Criterion, Bayesian Information Cri-
terion, and R2 statistics; multiple comparison-adjusted p val-
ues less than 0.05 were considered statistically significant. For 
location type strata with greater than or equal to five units 
reporting VAE data in 2014, we calculated pooled mean over-
all VAE and IVAC-plus incidence rates and ventilator utiliza-
tion ratios (VURs, total number of ventilator days divided 
by the total number of patient days). We calculated overall 
VAE and IVAC-plus rate distributions and VUR distributions 
for location type strata with greater than or equal to 20 units 
reporting greater than or equal to 50 ventilator days (or ≥ 50 
patient days, for VUR) in 2014.
Characteristics of VAEs, including patient age, sex, propor-
tions of patients with VAE who died, and times to events, were 
determined. Differences in time to event medians and dis-
tributions were tested for statistical significance using Mood 
median test and Kuiper empirical distribution function. We 
also described the pathogens reported for PoVAP and PrVAP, 
including methicillin-resistant Staphylococcus aureus (MRSA) 
and selected carbapenem-resistant Gram-negative bacteria 
(Supplemental Material, Supplemental Digital Content 1, 
http://links.lww.com/CCM/B934).
RESULTS
Healthcare Facilities and Locations
In 2014, 3,207 units in 1,824 healthcare facilities submitted 
32,772 adult location months of VAE data. Facilities partici-
pating in VAE surveillance were general acute care hospitals 
(1,588; 87.06%), LTACHs (110; 6.03%), critical access (69; 
3.78%), military (27; 1.48%), and surgical hospitals (10; 
0.55%). Twenty hospitals (1.10%) were other types. Common 
location types were medical/surgical (1,478; 46.09%), medical 
(383; 11.94%), and surgical cardiothoracic critical care units 
(232; 7.23%).
VAE and IVAC-Plus Incidence
VAE and IVAC-plus rates were calculated for noncritical care 
and critical care location types. Based on modeling results 
(Supplemental Material, Supplemental Digital Content 1, 
http://links.lww.com/CCM/B934), medical, medical-surgical, 
and surgical critical care units were further stratified accord-
ing to academic affiliation (major teaching affiliation vs other 
or no affiliation), and medical-surgical critical care units with 
nonmajor teaching affiliations were further stratified by unit 
bed size (> 15 vs ≤ 15 beds) (Tables 1 and 2).
Among critical care units, locations with the highest pooled 
mean rates per 1,000 ventilator days were trauma (11.79) and 
neurology (8.92) critical care units. Locations with the lowest 
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TAbLE 1. Overall Ventilator-Associated Event Incidence Rates, by Healthcare Facility 
Location Type, 2014
Location Type
Ventilator-Associated Event Incidence Rates (Per 1,000 Ventilator Days)









10 25 50 75 90
Critical care units
 Burn 36 (34) 125 19,087 6.55 0.00 0.94 6.52 12.84 18.07
 Medical cardiac 185 (181) 1,028 160,389 6.41 0.00 0.63 5.45 10.13 13.61
 Surgical 
cardiothoracic
232 (231) 1,457 236,350 6.16 0.00 0.84 4.93 8.68 12.79
 Long-term acute care 18 (18) 34 16,968 2.00 — — — — —
 Medical: major teaching 143 (142) 2,324 269,448 8.63 1.19 4.20 7.73 11.78 15.15
 Medical: nonmajor 
teaching
240 (212) 1,217 211,264 5.76 0.00 0.00 3.37 8.13 11.24
 Medical/surgical: 
major teaching








410 (408) 3,717 711,915 5.22 0.00 0.74 4.05 7.64 10.60
 Neurologic 25 (25) 228 25,574 8.92 1.16 3.14 8.60 12.29 19.23
 Neurosurgical 99 (99) 955 115,225 8.29 0.00 3.13 6.66 12.86 19.44
 Oncology medical/
surgical
7 (6) 13 5,028 2.59 — — — — —
 Respiratory 5 (5) 21 5,925 3.54 — — — — —
 Surgical: major 
teaching
106 (106) 1,351 152,512 8.86 0.50 3.78 9.01 12.20 16.19
 Surgical: nonmajor 
teaching
80 (77) 476 84,383 5.64 0.00 1.20 3.58 8.35 12.45
 Trauma 83 (82) 1,615 136,924 11.79 2.07 5.71 10.95 16.26 21.45
Inpatient wards
 Long-term acute care 118 (114) 143 163,611 0.87 0.00 0.00 0.00 0.82 2.99
 Medical 52 (32) 51 15,236 3.35 0.00 0.00 0.00 3.64 8.55
 Medical/surgical 65 (38) 53 21,646 2.45 0.00 0.00 0.00 1.97 6.06
 Hematopoietic stem 
cell transplant
6 (4) 16 1,077 14.86 — — — — —
 Pulmonary 13 (10) 36 8,582 4.19 — — — — —
 Rehabilitation 6 (4) 1 1,019 0.98 — — — — —
 Surgical 15 (2) 0 351 0.00 — — — — —
 Telemetry 12 (9) 0 2,704 0.00 — — — — —
Adult step-down units 124 (94) 239 50,319 4.75 0.00 0.00 0.00 4.59 9.95
Adult mixed acuity units 33 (26) 133 16,728 7.95 0.00 0.00 4.78 9.15 15.18
a	Numbers	in	parentheses	represent	the	total	number	of	units	reporting	≥	50	ventilator	days	in	2014.
b Percentile	distributions	shown	for	locations	with	≥	20	units	reporting	≥	50	ventilator	days	in	2014.
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TAbLE 2. Incidence Rates of Events Meeting the Infection-Related Ventilator-
Associated Complications, Possible Ventilator-Associated Pneumonia, or Probable 
Ventilator-Associated Pneumonia Definitions (Infection-Related Ventilator-Associated 
Complication-Plus), by Healthcare Facility Location Type, 2014
Location Type
Infection-Related Ventilator-Associated Complication-Plus Event Incidence Rates  










10 25 50 75 90
Critical care
 Burn 36 (34) 56 19,087 2.93 0.00 0.00 1.24 6.29 10.46
 Medical cardiac 185 (181) 326 160,389 2.03 0.00 0.00 1.42 3.18 5.06
 Surgical cardiothoracic 232 (231) 574 236,350 2.43 0.00 0.00 1.46 3.44 5.65
 Long-term acute care 18 (18) 15 16,968 0.88 — — — — —
 Medical: major teaching 143 (142) 793 269,448 2.94 0.00 1.14 2.34 4.12 5.84
 Medical: nonmajor 
teaching
240 (212) 421 211,264 1.99 0.00 0.00 0.94 2.40 4.27
 Medical/surgical: major 
teaching
222 (216) 943 336,602 2.80 0.00 0.00 2.01 3.97 5.61
 Medical/surgical: 
nonmajor teaching,  
≤ 15 beds
846 (701) 593 411,695 1.44 0.00 0.00 0.00 1.87 3.91
 Medical/surgical: 
nonmajor teaching,  
> 15 beds
410 (408) 1,293 711,915 1.82 0.00 0.00 1.10 2.67 4.34
 Neurologic 25 (25) 96 25,574 3.75 0.00 0.00 1.77 5.98 8.24
 Neurosurgical 99 (99) 397 115,225 3.45 0.00 0.90 2.46 5.30 7.16
 Oncology medical/surgical 7 (6) 2 5,028 0.40 — — — — —
 Respiratory 5 (5) 10 5,925 1.69 — — — — —
 Surgical: major teaching 106 (106) 526 152,512 3.45 0.00 0.59 2.98 5.57 7.41
 Surgical: nonmajor teaching 80 (77) 200 84,383 2.37 0.00 0.00 1.38 2.96 6.40
 Trauma 83 (82) 748 136,924 5.46 0.31 2.64 4.21 8.32 11.23
Inpatient wards
 Long-term acute care 118 (114) 64 163,611 0.39 0.00 0.00 0.00 0.00 1.51
 Medical 52 (32) 14 15,236 0.92 0.00 0.00 0.00 0.00 2.78
 Medical/surgical 65 (38) 9 21,646 0.42 0.00 0.00 0.00 0.00 1.49
 Hematopoietic stem cell 
transplant
6 (4) 3 1,077 2.79 — — — — —
 Pulmonary 13 (10) 7 8,582 0.82 — — — — —
 Rehabilitation 6 (4) 0 1,019 0.00 — — — — —
 Surgical 15 (2) 0 351 0.00 — — — — —
 Telemetry 12 (9) 0 2,704 0.00 — — — — —
Adult step-down units 124 (94) 75 50,319 1.49 0.00 0.00 0.00 1.15 4.01
Adult mixed acuity units 33 (26) 46 16,728 2.75 0.00 0.00 0.94 3.37 8.77
a	Numbers	in	parentheses	represent	the	total	number	of	units	reporting	≥	50	ventilator	days	in	2014.
b Percentile	distributions	shown	for	location	type	strata	with	≥	20	units	reporting	≥	50	ventilator	days	in	2014.
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TAbLE 3. Percentages of Ventilator-Associated Events Comprised of Infection-Related 
Ventilator-Associated Complication-Plus Events, by Healthcare Facility Location Type, 2014
Location Type















10 25 50 75 90
Critical care
 Burn 36 (34) 56 125 44.80 0.00 12.50 46.43 62.50 100.00
 Medical cardiac 185 (181) 326 1,028 31.71 0.00 14.29 28.57 50.00 66.67
 Surgical cardiothoracic 232 (231) 574 1,457 39.40 0.00 15.59 40.00 53.33 100.00
 Long-term acute care 18 (18) 15 34 44.12 — — — — —
 Medical: major teaching 143 (142) 793 2,324 34.12 10.71 23.81 34.62 45.45 62.50
 Medical: nonmajor 
teaching
240 (212) 421 1,217 34.59 0.00 16.67 33.33 50.00 100.00
 Medical/surgical: major 
teaching
222 (216) 943 2,613 36.09 0.00 21.11 33.33 50.00 66.67
 Medical/surgical: 
nonmajor teaching,  
≤ 15 beds
846 (701) 593 1,843 32.18 0.00 0.00 30.00 50.00 100.00
 Medical/surgical: 
nonmajor teaching,  
> 15 beds
410 (408) 1,293 3,717 34.79 0.00 16.67 33.33 50.00 80.00
 Neurologic 25 (25) 96 228 42.11 0.00 0.00 27.27 50.00 69.23
 Neurosurgical 99 (99) 397 955 41.57 0.00 25.00 39.74 58.65 100.00
 Oncology medical/
surgical
7 (6) 2 13 15.38 — — — — —
 Respiratory 5 (5) 10 21 47.62 — — — — —
 Surgical: major teaching 106 (106) 526 1,351 38.93 0.00 23.53 38.59 50.00 62.50
 Surgical: nonmajor 
teaching
80 (77) 200 476 42.02 0.00 26.79 43.25 53.39 87.50
 Trauma 83 (82) 748 1,615 46.32 28.57 35.00 48.65 60.00 72.00
Inpatient wards
 Long-term acute care 118 (114) 64 143 44.76 0.00 0.00 45.00 100.00 100.00
 Medical 52 (32) 14 51 27.45 0.00 0.00 29.09 50.00 83.33
 Medical/surgical 65 (38) 9 53 16.98 0.00 0.00 0.00 33.33 100.00
 Hematopoietic stem cell 
transplant
6 (4) 3 16 18.75 — — — — —
 Pulmonary 13 (10) 7 36 19.44 — — — — —
 Rehabilitation 6 (4) 0 1 0.00 — — — — —
 Surgical 15 (2) 0 0 — — — — —
 Telemetry 12 (9) 0 0 — — — — —
Adult step-down units 124 (94) 75 239 31.38 0.00 0.00 27.21 50.00 100.00
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rates per 1,000 ventilator days were LTACH (2.00) and oncology 
medical-surgical (2.59) critical care units. Among noncritical care 
units, the highest rates were in hematopoietic stem cell transplant 
(14.86) and mixed acuity units (7.95), whereas the lowest rates 
were in surgical and telemetry wards (with no reported VAEs). 
IVAC-plus rates largely mirrored overall VAE rates (Table 2).
The proportion of VAEs that were IVAC-plus varied among 
and within location types (Table 3). Among critical care 
location types, those with the highest proportion of IVAC-
plus events were respiratory critical care units, where the 
pooled mean percentage was 47.62%. By contrast, the critical 
care locations with the lowest proportion of IVAC-plus events 
(15.38%) were oncology medical-surgical critical care units. 
Within individual location types, the proportion of IVAC-plus 
events varied widely: for example, from 0% in some medical 
critical care units to 100% in others.
TAbLE 4. Ventilator Utilization Ratios, by Healthcare Facility Location Type, 2014
Location Type









10 25 50 75 90
Critical care
 Burn 36 (36) 19,087 79,163 0.24 0.09 0.17 0.21 0.33 0.42
 Medical cardiac 185 (185) 160,389 614,321 0.26 0.12 0.18 0.25 0.35 0.43
 Surgical cardiothoracic 232 (232) 236,350 736,590 0.32 0.14 0.20 0.28 0.39 0.49
 Long-term acute care 18 (18) 16,968 55,281 0.31 — — — — —
 Medical: major teaching 143 (143) 269,448 605,647 0.44 0.25 0.36 0.45 0.54 0.61
 Medical: nonmajor teaching 240 (237) 211,264 615,223 0.34 0.08 0.18 0.30 0.42 0.52
 Medical/surgical: major teaching 222 (221) 336,602 879,742 0.38 0.16 0.26 0.37 0.46 0.54
 Medical/surgical: nonmajor 
teaching, ≤ 15 beds
846 (822) 411,695 1,580,000 0.26 0.05 0.11 0.21 0.33 0.45
 Medical/surgical: nonmajor 
teaching, > 15 beds
410 (410) 711,915 2,190,000 0.32 0.18 0.25 0.34 0.42 0.50
 Neurologic 25 (25) 25,574 73,069 0.35 0.19 0.31 0.34 0.39 0.44
 Neurosurgical 99 (99) 115,225 368,353 0.31 0.17 0.23 0.32 0.40 0.46
 Oncology medical/surgical 7 (7) 5,028 16,696 0.30 — — — — —
 Respiratory 5 (5) 5,925 20,258 0.29 — — — — —
 Surgical: major teaching 106 (106) 152,512 402,782 0.38 0.24 0.30 0.38 0.47 0.54
 Surgical: nonmajor teaching 80 (79) 84,383 235,738 0.36 0.19 0.27 0.35 0.41 0.50
 Trauma 83 (82) 136,924 291,852 0.47 0.34 0.40 0.46 0.52 0.57
Inpatient wards
 Long-term acute care 118 (118) 163,611 794,483 0.21 0.06 0.09 0.19 0.28 0.45
 Medical 52 (52) 15,236 294,965 0.05 0.00 0.00 0.03 0.05 0.07
 Medical/surgical 65 (65) 21,646 379,475 0.06 0.00 0.01 0.02 0.05 0.19
 Hematopoietic stem cell 
transplant
6 (6) 1,077 19,045 0.06 — — — — —
 Pulmonary 13 (13) 8,582 75,666 0.11 — — — — —
 Rehabilitation 6 (6) 1,019 19,909 0.05 — — — — —
 Surgical 15 (15) 351 32,644 0.01 — — — — —
 Telemetry 12 (12) 2,704 85,844 0.03 — — — — —
Adult step-down units 124 (124) 50,319 572,899 0.09 0.01 0.02 0.05 0.13 0.23
Adult mixed acuity units 33 (33) 16,728 105,178 0.16 0.03 0.05 0.12 0.23 0.36
a	Numbers	in	parentheses	represent	the	total	number	of	units	reporting	≥	50	patient	days	in	2014.
b Percentile	distributions	shown	for	locations	with	≥	20	units	reporting	≥	50	patient	days	in	2014.




Ventilator utilization also varied widely (Table 4). In critical 
care units, the pooled mean VUR was highest in trauma (0.47) 
and lowest in burn critical care units (0.24). Not surprisingly, 
pooled mean VURs were lower in noncritical care locations, 
ranging from 0.01 in surgical wards to 0.21 in LTACH wards.
Event Characteristics
Of 19,714 VAEs, 19,689 were from location types with greater 
than or equal to five units reporting data and 25 were from loca-
tion types with less than five units reporting data. Thirty-eight 
events were excluded because of errors in reported mechani-
cal ventilation initiation or event dates. Among the remaining 
19,676 VAEs, 12,474 (63.4%) were VACs, 4,002 (20.3%) were 
IVACs, and 3,200 (16.3%) were PoVAPs or PrVAPs.
Mortality among patients with VAEs was high, with approx-
imately 31% dying during their hospitalizations (Table 5). 
Patients with VAC only were significantly older, less likely to 
be male and more likely to die during their hospitalizations 
than patients with IVAC-plus. Patients with VAC only tended 
to have event onset dates earlier in mechanical ventilation than 
patients with IVAC-plus. Approximately 36% of VAEs had 
onset dates on days 3 or 4 of mechanical ventilation. Overall, 
15,458 VAEs (78.6%) had onset dates on or after ventilator day 
or hospital day 5.
Among the 3,200 PoVAP and PrVAP events, 3,151 patho-
gens were reported for 2,517 events (78.7%). Common patho-
gens were S. aureus (892; 28.3%), Pseudomonas aeruginosa 
(412; 13.1%), Klebsiella pneumoniae (249; 7.9%), Escherichia 
coli (188; 6.0%), and untypeable Haemophilus influenzae (147; 
4.7%). Among 826 tested S. aureus isolates, 308 (37.3%) were 
reported to be MRSA. Among 331 tested P. aeruginosa isolates, 
103 (31.1%) were reported to be carbapenem resistant. Among 
171 tested K. pneumoniae and 142 tested E. coli isolates, 24 
(14.0%) and 0, respectively, were reported to be carbapenem 
resistant.
DISCUSSION
This is the first national report of VAE rates and characteris-
tics. VAE incidence, proportions of VAEs defined as infection-
related, and ventilator utilization varied within and among 
inpatient location types. Furthermore, VAEs occurred in 
patients with substantial inpatient mortality. The pathogen 
profile of VAEs defined as PoVAP or PrVAP was similar to pre-
viously reported traditional VAP pathogen profiles. Methicillin 
resistance among VAE S. aureus isolates was lower than previ-
ously reported for VAP (https://shea.confex.com/shea/2011/
webprogram/Paper4109.html), and carbapenem resistance in 
selected Gram-negative pathogens was high: 31% in P. aeru-
ginosa and 14% in K. pneumoniae. We did not determine 
whether laboratories were using revised carbapenem break-
points for Enterobacteriaceae.
Studies have shown that most VAEs are due to pneumonia, 
pulmonary edema, atelectasis, and acute respiratory distress 
syndrome (7, 9, 10). Data suggest that some of these conditions 
may be prevented (11, 12), so it stands to reason that VAEs may 
also be prevented. Still, there is a paucity of published evidence 
establishing VAE preventability. This is VAE’s most impor-
tant limitation, and additional studies are needed. Boyer et 
al (7) evaluated 67 events meeting modified VAE definitions 
and found that most were due to the conditions above; 25 
(37.3%) were deemed preventable. In a matched case-control 
analysis, Lewis et al (13) identified care-related factors associ-
ated with VAC, including positive fluid balance and manda-
tory mechanical ventilation modes, and with IVAC, including 
TAbLE 5. Characteristics of Patients With Ventilator-Associated Events, 2014
Characteristic
Overall Ventilator-







(n = 7,202) pa
Age, median years (IQR) 60.48 (49.51–70.44) 61.25 (50.69–71.17) 59.09 (47.15–69.20) < 0.0001
Male, n (%) 12,117 (61.58) 7,538 (60.43) 4,579 (63.58) < 0.0001
Time from admissionb 
to event, median days 
(IQR)c
8 (5–14) 8 (5–14) 8 (5–13) < 0.0001d
Time from intubation to 
event, median days 
(IQR)e
6 (4–9) 5 (4–9) 6 (4–9) < 0.0001
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receipt of benzodiazepines before intubation. Multiple recent 
studies have evaluated approaches to preventing VAEs, some 
with promising results. In two of these (14, 15), VAC and IVAC 
definitions were retrospectively applied to patients in the study 
datasets to evaluate the impact of the intervention on VAE 
rates. Analysis of data from a study of the impact of adherence 
to VAP prevention guidelines on VAP rates in Canadian ICUs 
showed that increased adherence was associated with lower 
VAC but not lower IVAC rates (14). Analysis of data from a 
multicenter clinical trial of a β-type natriuretic peptide-driven 
fluid management strategy to prevent VAP showed that VAP 
and VAC occurred less frequently among patients randomized 
to the fluid management strategy (15). Another study, the CDC 
Prevention Epicenters’ Wake Up and Breathe Collaborative 
(16), evaluated the preventability of VAEs through improv-
ing compliance with daily, paired spontaneous awakening 
and breathing trials (SATs and SBTs). This study showed that 
increases in SAT and SBT performance were associated with a 
decrease in the risk of overall VAE (odds ratio [OR], 0.63; 95% 
CI, 0.42–0.97) and IVAC (OR, 0.35; 95% CI, 0.17–0.71) per 
episode of mechanical ventilation (16). Notably, no change in 
VAE risk was observed when data were analyzed per ventila-
tor day, possibly because the intervention successfully reduced 
patients’ exposure to mechanical ventilation (16). These 
findings led CDC to make an optional VAE denominator— 
episodes of mechanical ventilation—available for NHSN users 
to report beginning in 2015 (17). Although these studies sug-
gest that VAEs are preventable, investigators for a single-center 
clinical trial of subglottic suctioning for prevention of VAP 
retrospectively applied the VAC and IVAC definitions to study 
subjects and found no difference in VAC or IVAC prevalence 
in the study groups (18). More work is needed to determine 
the extent to which VAEs can be prevented through implemen-
tation of evidence-based practices that reduce the occurrence 
of clinical events most commonly associated with VAEs. This 
is particularly important because VAE is now included in the 
Centers for Medicare & Medicaid Services Long Term Care 
Hospital Quality Reporting Program (http://www.cdc.gov/
nhsn/pdfs/cms/ltac/ltch_vae_guidance.pdf).
A limitation of surveillance definitions in general, including 
VAE, is that because they rely on criteria that are objective and 
feasible to assess across healthcare facilities, they are imperfect 
proxies for the clinical conditions they attempt to identify. In 
one study, 12% of VACs and 6% of IVACs had no associated 
clinical condition (19), whereas in another, 31% of VACs had 
no discernible cause identified in the medical record, although 
some of these patients were being treated with antimicrobial 
drugs and/or furosemide around the time of the VAC (9). 
NHSN users have expressed concerns that because VAE defini-
tions are met through sustained increases in positive end-expi-
ratory pressure (PEEP) or Fio
2
 ventilator settings, patients can 
have VAEs without corresponding clinically important events, 
particularly in instances in which the PEEP has been increased 
to allow for a concomitant Fio
2
 reduction. We are exploring 
modifications to the definitions that address this issue. Users 
may also object when an event meeting the VAC definition goes 
on to meet IVAC because of a change in antimicrobial treat-
ment from a broad-spectrum regimen to one that is appropri-
ately tailored to the results of diagnostic testing. In these cases, 
we have instructed users that an IVAC is not a worse or more 
serious surveillance event than a VAC—it merely identifies the 
VAE as one that is potentially infectious in nature. Presumably, 
the antimicrobial regimen change occurred because the provid-
ers believed that they were treating an infection, and so report-
ing the event as an IVAC rather than a VAC is appropriate and in 
keeping with the intent of the definitions. Modifications could 
be considered to allow users to enter data into NHSN about 
the antimicrobial treatment that led to an IVAC determination, 
to inform antimicrobial stewardship activities. Indeed, French 
investigators who evaluated 3,028 ICU patients for modified 
VAC and IVAC events found that VAC and IVAC rates were 
highly correlated with antibiotic use (20).
We have presented VAE rate data in various inpatient loca-
tion type strata, similar to the approach utilized for reporting 
other NHSN device-associated event rates (8). In the future, it 
will be important to consider whether patient-level complex-
ity and severity of illness indicators can be incorporated into 
NHSN. Although collecting and reporting such indicators 
could mean additional burden on the NHSN user, maximizing 
opportunities to automate data collection from electronic health 
records (EHR) can mitigate this burden, and such information 
may improve risk adjustment, the validity of VAE rate compari-
sons, and the usefulness of the data for improving patient safety.
In addition, as more facilities develop approaches to elec-
tronically detect VAEs, it is critical for CDC to continue to pro-
vide guidance and a means of validating electronic methods to 
ensure NHSN data quality. Investigators have shown that VAE 
detection is susceptible to seemingly minor differences in the 
implementation of electronic algorithms (19). CDC continues 
to develop tools for healthcare facilities and EHR vendors to 
use in validating their own electronic VAE algorithms (21).
Despite its limitations, studies have already demonstrated 
that VAE surveillance offers significant benefits, including the 
reliability of the definitions and their potential to be automated 
and to reduce surveillance burden. Nuckchady et al (22) com-
pared automated surveillance for VAC and potential IVAC to 
manual VAE surveillance and found that the sensitivity, speci-
ficity, and positive and negative predictive values of the auto-
mated method exceeded 93%. The investigators also found that 
over a 6-month period, use of the automated method saved 94 
hours of staff time when compared with the time required for 
manual surveillance. Similarly, Mann et al (23) found that when 
compared with intensivist medical record review, an automated 
method to identify VACs had 100% sensitivity, specificity, and 
positive and negative predictive values and was time efficient. 
However, manual VAE surveillance performed by other hospital 
staff (infection preventionists and an infection control fellow) 
in this same study was time-consuming and missed a sub-
stantial number of VACs (23). Although there was variability 
in VAC detection by these staff members, interobserver agree-
ment as measured by the κ statistic still exceeded 0.6. Unlike 
the variability in VAP detection using traditional surveillance 
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definitions, which typically arose from differences in the assess-
ments of subjective definition criteria and was difficult to 
resolve, the variability in VAE detection in the Mann et al (23) 
study was due to readily correctable errors in applying VAC cri-
teria. McMullen et al (24) also reported good agreement when 
comparing a strategy of automated VAC and IVAC detection 
plus manual chart review by infection preventionists for PVAPs 
to an approach using prospective, manual VAE surveillance by 
pulmonary physicians and critical care unit staff (κ, 0.81). This 
is better agreement than has been reported previously for tradi-
tional VAP surveillance definitions (25, 26).
CONCLUSIONS
There is an increasing need for objective, practical approaches to 
national HAI surveillance that facilitate valid comparisons among 
facilities and that lead to healthcare quality improvement. It seems 
likely, then, that the healthcare-associated event surveillance of 
the future will increasingly involve automated, electronic detec-
tion and reporting of measures that are proxies for clinical events 
rather than measures that hew to diagnostic approaches at the 
bedside, which are often too complex and subjective to be used in 
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